The launch of 750mcg teriparatide injection in Australia has seen modest uptake. Currently, it’s primarily prescribed for patients with severe osteoporosis who other therapies have proven inadequate . Obtaining this stronger formulation can be restricted due to healthcare authorization requirements and limited clinic supply . Although some provi… Read More